FACT announces new educational opportunities for collection, processing, cord blood, and clinical cellular therapy colleagues. FACT representatives will be in attendance for all upcoming workshops to provide examples, discuss challenges, and answer questions.
All upcoming events will have a separate track for inspector trainees. Workshops include:
- FACT Cellular Therapy Collection Workshop at the 2019 ASFA Meeting
- FACT Cellular Therapy & Cord Blood Inspection at Accreditation Workshop at the 2019 Annual ISCT Meeting
- ISCT-FACT Quality Boot Camp at 2019 ISCT Annual Meeting
- FACT Cellular Therapy Inspection and Accreditation Workshop at the Canadian Bone Marrow Transplant Group Annual Meeting
- WMDA-NetCord & FACT Cord Blood Day at the Cord Blood Connect International Congress
Memorandum of Understanding Signed by FACT and SBTMO to Develop Joint Accreditation Program in Brazil
The Foundation for the Accreditation of Cellular Therapy (FACT) and the Sociedade Brasileira de Transplante de Medula Óssea (SBTMO), the Brazilian Society of Bone Marrow Transplantation, have announced its formal partnership to develop a joint FACT-SBTMO Cellular Therapy Accreditation Program in Brazil.
The agreement, in the form of a Memorandum of Understanding (MoU), formalizes the mutual interaction and strengthens the existing relationship between the SBTMO and FACT at the strategic and working level, focusing on standardization and accreditation of cellular therapy in Brazil.
Dr. Nelson Hamerschlak, SBTMO President states, “This partnership will bring a higher level of quality and outcomes for all Brazilian bone marrow transplant centers.” Dr. Hamerschlak leads the Hospital Israelita Albert Einstein (HIAE) in Brazil, the first Bone Marrow Transplantation Center in Latin America to receive FACT accreditation. HIAE is accredited for autologous and allogenic transplantation and cord blood banking.
For over 20 years, FACT has established international standards for hematopoietic cellular therapy product collection, processing, and administration. FACT administers its accreditation program in 25 countries. “The collaboration between FACT and SBTMO will support efforts to improve quality and patient safety at cellular therapy programs in Brazil in accordance with FACT-JACIE Standards,” said Linda Miller, FACT Chief Executive Officer.
“Through this partnership, FACT and SBTMO will work to increase access for patients to internationally accredited blood and marrow transplant programs in Brazil,” states Dr. Dennis Gastineau, FACT President.